Skip to content
Open access

Pathogenic mutations in ATAD3A cause dysregulation of RagC/D-TFEB axis and disrupt lysosomal homeostasis

Sep 2026 · bioRxiv · 0 citations
Biology Medicine

TL;DR

A novel role for the mitochondrial resident protein ATAD3A is revealed in modulating lysosomal homeostasis through regulation of the mTORC1-TFEB axis, providing a mechanistic link between impaired mitochondrial and lysosomal homeostasis in a neurodevelopmental disorder.

Abstract

We previously discovered that a de novo variant p.R528W in ATAD3A, encoding a mitochondrial membrane-anchored protein, causes a human neurological syndrome. While ATAD3A mutations induce aberrant lysosomal expansion accompanied by undigested material in the lysosomes, how mutant ATAD3A disrupts lysosomal homeostasis and whether this contributes to neurodevelopmental defects remain unknown. Here we show that pathogenic ATAD3A p.R528W expression disrupts the mTORC1-TFEB axis as revealed by dysregulation of mTORC1 substrate phosphorylation, TFEB nuclear localization, and CLEAR gene activation associated with lysosomal biogenesis. ATAD3A binds to lysosome-localized Rag C/D GTPases, which constitute a platform for TFEB recruitment, with pathogenic variants increasing this association and thereby decreasing lysosomal localization of Rag GTPases. Importantly, overexpression of RagC or RagD restores TFEB phosphorylation in human cells expressing p.R528W, and RagC- D overexpression or TFEB/Mitf knockdown rescues lysosomal expansion and neurodevelopmental defects in Drosophila. These data indicate that disrupted Rag GTPase recruitment to lysosomes and subsequent aberrant TFEB/Mitf activation contribute to neurodevelopmental and lysosomal phenotypes caused by pathogenic mutations in ATAD3A. Our work reveals a novel role for the mitochondrial resident protein ATAD3A in modulating lysosomal homeostasis through regulation of the mTORC1-TFEB axis, providing a mechanistic link between impaired mitochondrial and lysosomal homeostasis in a neurodevelopmental disorder.

Read PDF

Similar papers

Open access Sep 2026

TRAF7 mutations stabilize K/NRAS and hyperactivate MAPK signaling to cause CAFDADD neurodevelopmental defects

The MAPK-ERK1/2 pathway plays a crucial role in neurodevelopment during embryogenesis, and the hyperactivation of this signaling cascade serves as a pathological hallmark for various neurodevelopmental disorders. Germline variants in TRAF7, encoding a RING-type E3 ubiquitin ligase, are genetically associated with cardi...

Man Xiao, Yang Liu, Xiao-Zhen Song et al. · 0 citations
Open access Oct 2026

Chronic TFE3 activation in TFE3-associated neurodevelopmental disorder drives metabolic rigidity, lysosomal failure, and cell-extracellular matrix destabilization

The transcription factor TFE3 coordinates cellular adaptation to stress. While its acute activation is cytoprotective, chronic TFE3 dysregulation is linked to diverse pathologies. Here, we characterize the cellular landscape of TFE3-NDD, a recently described neurodevelopmental disorder caused by mutations that disrup...

J. Martina, Akriti Prashar, A. M. Pasapera et al. · 0 citations
Conference Open access Oct 2026

Upstream and Downstream Convergence: How do the GBA1 and LRRK2 genes disrupt PINK1/Parkin-Mediated Mitophagy?

Parkinson’s Disease (PD) is a complex progressive neurodegenerative disease with certain cases exhibiting non-idiopathic forms. Understanding this allows for a better understanding about the disease and treatment options. The 2 main genetic forms of PD are mutations in the Glucosylceramidase Beta 1 (GBA1) and Leucine-R...

Nikhil Rahul · 0 citations
Open access Nov 2026

Pharmaco-genetic evidence of presymptomatic lysosomal dysfunction coupled to detrimental DPR secretion in Drosophila Models of C9orf72-linked ALS/FTD

Hexanucleotide repeat expansions in C9orf72, the most common genetic cause of Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), drive neurodegeneration through both loss of gene function and toxic gain-of-function mechanisms, including transcription of repeat RNA and repeat-associated non-AUG (RAN)...

Paulien H. Smeele, V. Ferrari, G. Spina et al. · 0 citations
Open access Nov 2026

A DNM1L GTPase Effector Domain Deletion Causes Intermediate Defects in Peroxisomal and Mitochondrial Dynamics and Reveals a Targetable Metabolic Vulnerability

DNM1L encodes dynamin-related protein 1 (DRP1), a key GTPase regulating mitochondrial and peroxisomal dynamics. Pathogenic DNM1L variants are associated with a broad spectrum of neurodevelopmental and neurodegenerative disorders, with phenotypic severity varying by affected protein domain. While variants in the GTPase...

Saurabh Srivastav, S. Jangam, Jonathan C. Andrews et al. · 0 citations
Open access Oct 2026

Progranulin haploinsufficiency disrupts cathepsin D function, resulting in lysosomal abnormalities and elevated TDP-43 levels in the mouse brain

Introduction Frontotemporal dementia (FTD) is a leading cause of early-onset neurodegeneration, frequently linked to mutations in the GRN gene, which encodes the protein progranulin (PGRN). PGRN is known to play a crucial role in lysosomal function, and its deficiency contributes to FTD pathogenesis. Here, we examined...

Raheem Fazal, Arun Kumar Tharkeshwar, S. Beel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.